Creo Medical Group Plc (CREO) Ord GBP0.001
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Creo device used in 'groundbreaking' lung cancer procedure
1 March 2024 14:06
(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.
-
Creo Medical FY revenues up double digits
7 February 2024 11:49
(Sharecast News) - Medical device company Creo Medical said on Wednesday that 2023 was "a pivotal year" for the firm, with new products supporting "strong growth" and leading to a...
-
Creo launches 'Speedboat Ultraslim' with first UK procedure
13 December 2023 14:28
(Sharecast News) - Creo Medical Group announced a significant milestone for its Speedboat UltraSlim medical device in the field of surgical endoscopy on Wednesday.
-
Creo Medical gets US FDA clearance for Speedboat UltraSlim
1 November 2023 14:28
(Sharecast News) - Medical device company Creo Medical Group announced on Wednesday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Speedboat UltraSlim device.
-
Creo Medical accelerating EU launch of Speedboat UltraSlim
25 October 2023 13:44
(Sharecast News) - Creo Medical Group announced the acceleration of its EU launch of the 'Speedboat UltraSlim' device by around 18 months on Wednesday.
-
Creo Medical's 'Speedboat Inject' used for first time in Europe
26 June 2023 10:35
(Sharecast News) - Surgical endoscopy specialist Creo Medical announced on Monday that Dr Adolfo Parra-Blanco at Nottingham University Hospital NHS Trust had become the first clinician to perform an upper...
-
Creo's Speedboat Inject to be evaluated by NICE
1 June 2023 15:14
(Sharecast News) - Surgical endoscopy specialist Creo Medical Group announced on Thursday that its 'Speedboat Inject' product had been chosen by the National Institute for Health and Care...
-
Creo Medical achieves second Albyn earn-out target
14 April 2023 12:10
(Sharecast News) - Creo Medical Group announced on Friday that it has successfully achieved the earn-out target for the 12 months ended July last year, over the acquisition of Albyn Medical.
-
Creo raising at least £25m to progress various programmes
16 February 2023 18:19
(Sharecast News) - Medical device developer Creo Medical Group announced a fundraising of at least £25m net of expenses on Thursday, to progress its electrosurgical device programmes.
-
Creo Medical signs IP licence deal with CMR Surgical
24 October 2022 15:04
(Sharecast News) - Surgical endoscopy device company Creo Medical Group has signed a non-exclusive intellectual property licence and a royalty agreement with surgical robotics business CMR Surgical, it...
-
Creo Medical ends year with revenue above forecasts
3 February 2022 11:36
(Sharecast News) - Surgical endoscopy medical device company Creo Medical Group said it continued to deliver on its three-tiered 'build, buy and partner' strategy in a trading update on Thursday,...
-
Creo Medical acquires Aber Electronics for undisclosed sum
12 November 2021 09:38
(Sharecast News) - Medical device company Creo Medical Group has acquired power amplifier and radio frequency products manufacturer and designer Aber Electronics for an undisclosed, fixed cash consideration,...
Company announcements Announcements
-
Holding(s) in Company
20 March 2024 16:52
Creo Medical Group
-
Holding(s) in Company
13 March 2024 15:05
Creo Medical Group
-
LTIP Awards
11 March 2024 14:00
Creo Medical Group
-
Holding(s) in Company
6 March 2024 16:35
Creo Medical Group
-
Trading Update - Replacement
7 February 2024 09:12
Creo Medical Group
-
Trading Update
7 February 2024 07:00
Creo Medical Group
-
Award of Shares under Share Incentive Plan
22 January 2024 07:00
Creo Medical Group
-
Capital Markets Day
7 November 2023 07:00
Creo Medical Group
-
Speedboat® UltraSlim: US FDA Clearance
1 November 2023 07:00
Creo Medical Group
-
SB UltraSlim: EU launch accelerated by 18 months
25 October 2023 07:00
Creo Medical Group
-
Change of Nominated Adviser and Joint Broker
16 October 2023 10:16
Creo Medical Group
-
Half-year Report
12 September 2023 07:00
Creo Medical Group
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.